In the News
ADA updates Standards of Care in Diabetes
The updates, which were released by the American Diabetes Association (ADA) in June, cover therapy to delay onset of type 1 diabetes and screening for nonalcoholic fatty liver disease.
More than a quarter of diabetes patients have diabetic retinopathy, study estimates
Researchers calculated that in 2021, 9.60 million people in the U.S. had diabetic retinopathy, including 1.84 million with vision-threatening diabetic retinopathy, based on data from the National Health and Nutrition Examination Survey and insurance claims, among other sources.
Younger, leaner patients may have undiagnosed type 2 diabetes, study finds
An analysis of 56 national health surveys throughout the world found that a substantial proportion of patients with a fasting plasma glucose level of 126 mg/dL (7.0 mmol/L) or greater may be younger than age 35 years and/or be in the underweight or normal weight category.
MKSAP quiz: Obesity and type 2 diabetes
This month's quiz asks readers to evaluate a 45-year-old woman for management of obesity and type 2 diabetes mellitus diagnosed 1 year ago. Her only medication is metformin, 850 mg twice daily.
Spotlight on weight loss drugs
The American Society of Anesthesiologists released guidance on preoperative management of glucagon-like peptide-1 receptor agonists, and recent studies looked at the effects of semaglutide, retatrutide, and orforglipron on weight in patients with and without diabetes.
Crowdfunding campaigns often focus on overall cost of diabetes, rarely mention insulin
A quarter of fundraisers for patients with diabetes reported that the patient had insurance, and many mentioned noncovered costs such as lost wages, healthy food, and diabetic alert dogs.
In types 1 and 2 diabetes, weekly basal insulin Fc was noninferior to daily insulin degludec for HbA1c at 26 wk
The arrival of once-weekly insulin will undoubtedly be welcomed by patients and clinicians, but the advantages of fewer shots will have to be weighed against less flexibility in dosing of basal insulin, an ACP Journal Club commentary said.